Suchergebnisse - "I031V2H011"

PubPharm (3.398)

1

Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia

enthalten in: Clinical rheumatology | 2024

von An, Q. | Ma, R. | Yuan, D. | +8

2

Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease : a prospective study

enthalten in: International ophthalmology | 2024

von Lee, C. | Park, J. | Kim, Y. | +1

3

Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study) : a multicenter, post-marketing, non-interventional, observational trial

enthalten in: Clinical rheumatology | 2024

von Athanassiou, P. | Katsimbri, P. | Bounas, A. | +23

4

Responsiveness to Tocilizumab in Anti-Acetylcholine Receptor-Positive Generalized Myasthenia Gravis

enthalten in: Aging and disease | 2024

von Jia, D. | Zhang, F. | Li, H. | +4

5

Prevention of bleomycin-induced pulmonary fibrosis by vaccination with the Tocilizumab mimotope

enthalten in: Human vaccines & immunotherapeutics | 2024

von Guo, J. | Yang, L. | Song, H. | +1

6

Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy

enthalten in: International immunopharmacology | 2024

von Pu, Y. | Zhao, Y. | Qi, Y. | +9

7

Tocilizumab treatment in COVID-19 patients : therapy's side effects and effect on mortality

enthalten in: European review for medical and pharmacological sciences | 2024

von Ayvat, P. | Kayhan Omeroglu, S.

8

Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease : A subgroup analysis of a global, randomised, controlled Phase 3 trial

enthalten in: Modern rheumatology | 2024

von Kuwana, M. | Takehara, K. | Tanaka, Y. | +4

9

Tocilizumab in chronic active antibody-mediated rejection : rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)

enthalten in: Trials | 2024

von Streichart, L. | Felldin, M. | Ekberg, J. | +10

10

Improvement in joint inflammation is accompanied by reduction in arterial inflammation : Tocilizumab in rheumatoid arthritis

enthalten in: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology | 2024

von Zureigat, H. | Civieri, G. | Abohashem, S. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[340]